The FDA this week released a warning letter it sent to cosmetic device maker Surgisil over unapproved marketing of its Perma Facial Implant device. The letter follows an inspection of the company’s facilities in Plano, Texas, during which an FDA investigator determined that the company is marketing its Perma Facial Implant for indications outside of […]